Related Experiment Video
Updated: Aug 2, 2025

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Factors affecting successful antituberculosis treatment: a single-center experience
Marcella Cardoso Gonçalves1, Amanda Aparecida Silva de Aguiar2, Ana Paula Biadola3
1Estratégia Saúde da Família - Bauru (SP), Brazil.
Low education and living with HIV/AIDS significantly impact tuberculosis treatment success. Identifying these factors helps improve public health strategies for better tuberculosis outcomes in Brazil.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Tuberculosis (TB) treatment success rates are crucial for controlling the disease.
- Identifying factors influencing treatment outcomes can guide targeted public health interventions.
- Understanding patient vulnerabilities is key to improving TB management strategies.
Purpose of the Study:
- To investigate factors affecting successful antituberculosis treatment outcomes.
- To analyze the association between social and clinical factors and TB treatment success.
- To inform health actions aimed at increasing the TB treatment success rate in Brazil.
Main Methods:
- Retrospective study of 348 TB patients treated between 2010 and 2016 at a reference service in Brazil.
- Exclusion of patients from the penitentiary system and those with resistant or multidrug-resistant TB.
- Logistic regression analysis to identify factors associated with successful (cured) or unsuccessful (default, death) treatment outcomes.
Main Results:
- The overall TB treatment success rate was 85.96% during the study period.
- Patients with less than 8 years of education had a higher likelihood of unfavorable treatment outcomes (OR 1.66).
- People living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) had a lower likelihood of successful treatment (OR 0.23).
Conclusions:
- Low educational attainment is a significant vulnerability factor for unfavorable TB treatment outcomes.
- Living with HIV/AIDS is strongly associated with reduced success in antituberculosis treatment.
- These findings highlight the need for tailored support for vulnerable TB patients to improve treatment success rates.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...

